Rockefeller Capital Management L.P. Has $999,000 Stock Holdings in Acadia Healthcare Company, Inc. $ACHC

Rockefeller Capital Management L.P. grew its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 7,490.9% in the fourth quarter, HoldingsChannel reports. The fund owned 70,368 shares of the company’s stock after acquiring an additional 69,441 shares during the period. Rockefeller Capital Management L.P.’s holdings in Acadia Healthcare were worth $999,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in ACHC. EverSource Wealth Advisors LLC raised its holdings in shares of Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares during the last quarter. Federated Hermes Inc. boosted its holdings in Acadia Healthcare by 1.5% during the fourth quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock worth $623,000 after purchasing an additional 668 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in Acadia Healthcare by 0.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock valued at $1,063,000 after purchasing an additional 696 shares in the last quarter. Public Employees Retirement System of Ohio increased its stake in Acadia Healthcare by 2.8% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock valued at $776,000 after buying an additional 867 shares during the last quarter. Finally, Treasurer of the State of North Carolina lifted its position in Acadia Healthcare by 2.1% during the 2nd quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock worth $964,000 after buying an additional 867 shares in the last quarter.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. TD Cowen increased their price objective on shares of Acadia Healthcare from $24.00 to $30.00 and gave the stock a “buy” rating in a research note on Tuesday, April 28th. Cantor Fitzgerald upped their target price on Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a report on Friday, May 1st. KeyCorp reissued an “overweight” rating and set a $30.00 price target on shares of Acadia Healthcare in a research report on Wednesday, May 27th. Zacks Research upgraded Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research note on Thursday, March 5th. Finally, UBS Group boosted their price target on Acadia Healthcare from $27.00 to $31.00 and gave the stock a “buy” rating in a research report on Friday, April 17th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Acadia Healthcare has an average rating of “Hold” and a consensus price target of $26.85.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $31.91 on Friday. The company has a market cap of $2.93 billion, a PE ratio of -2.61, a price-to-earnings-growth ratio of 10.42 and a beta of 0.64. The firm has a 50-day moving average of $25.62 and a 200-day moving average of $21.16. Acadia Healthcare Company, Inc. has a one year low of $11.43 and a one year high of $32.82. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company had revenue of $828.80 million for the quarter, compared to analysts’ expectations of $823.51 million. During the same period in the prior year, the firm earned $0.40 EPS. Acadia Healthcare’s quarterly revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, equities analysts forecast that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.